中文 | English
Return
Total: 335 , 1/34
Show Home Prev Next End page: GO
Author:(Shi-Ya LIU)

3.Clinical analysis of 15 cases with vaginal intraepithelial neoplasia and vaginal cancer after operations of cervical cancer or cervical intraepithelial neoplasia

Qi LIU ; Ya SHI ; Qin ZHANG ; Yingchun SHUI ; Qun GUAN ; Qunli SHI

Journal of Medical Postgraduates 2014;(6):623-626

4.Experimental study on effect of model on hepatic fibrosis with Aralia chinesis.

Miao HUANG ; Xin LIU ; Lei DONG ; Hai-tao SHI ; Ya-ping LIU ; Chao LIU

China Journal of Chinese Materia Medica 2015;40(21):4251-4255

5.Analysis and Discussion on Calculating Likelihood Ratio of DNA Mixture.

Ying LIU ; He REN ; Lin-lin GAO ; Yan SHI ; Chong CHEN ; Ya-cheng LIU

Journal of Forensic Medicine 2015;31(6):441-444

6.Analysis laboratory results of three cases of COVID-19 complicated with falciparum malaria

ZHAO Rong ; SHI Ya-ling ; LIU Yan-xia ; JIANG Hong-ya ; FAN Yin-min ; ZHANG Zhan-feng

China Tropical Medicine 2023;23(1):106-

7.Factors Affecting Sterilization of HBV on Dental Hand Piece

Lei SHI ; Guangliang NIU ; Jinghua TIAN ; Hui ZHAO ; Ya LIU ; Yao XIE

Chinese Journal of Nosocomiology 2006;0(06):-

8.The effects of levocitirize dihydrochloride on serum IL-13 and IL-18 in patients with cough variant asthma

Mingsheng LI ; Ya LIU ; Xiaolu ZHENG ; Jifu LI ; Liya SHI ; Shuangyin CAO ; Mingyou LU

Chinese Journal of Primary Medicine and Pharmacy 2009;16(3):445-446

9.Consistency of T-cell receptor gene mutation between lymphocytes in rats after irradiation in vivo and in vitro

Yan SHI ; Wei LIU ; Dianjun HOU ; Ya MA ; Jianwei QIAO ; Feng LU ; Ximei SHANG

Chinese Journal of Radiological Medicine and Protection 2010;30(5):561-563

10.Preparation and Properties of Mesalazine β-Cyclodextrin Inclusion Compound

Chunling JIANG ; Conghai LIU ; Chenggui ZHANG ; Hengyuan XIE ; Guangya CAI ; Ya ZHOU ; Shi CHEN

China Pharmacist 2017;20(2):266-270

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 335 , 1/34 Show Home Prev Next End page: GO